PHARMAVAL PLASTIC : revenue, balance sheet and financial ratios

PHARMAVAL PLASTIC is a French company founded 5 years ago, specialized in the sector Fabrication de pièces techniques à base de matières plastiques. Based in LE VAUDREUIL (27100), this company of category PME shows in 2023 a revenue of 3.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMAVAL PLASTIC (SIREN 892141862)
Indicator 2024 2023 2022 2021
Revenue N/C 3 903 286 € 4 407 204 € N/C
Net income 41 444 € -74 245 € 316 825 € 22 856 €
EBITDA N/C -45 299 € 513 390 € N/C
Net margin N/C -1.9% 7.2% N/C

Revenue and income statement

In 2024, PHARMAVAL PLASTIC generates positive net income of 41 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 23 k€ -> 41 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

41 444 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 171%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

171.15%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

19.37%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

62.6%

Solvency indicators evolution
PHARMAVAL PLASTIC

Sector positioning

Debt ratio
171.15 2024
2022
2023
2024
Q1: 7.54
Med: 27.74
Q3: 63.65
Watch

In 2024, the debt ratio of PHARMAVAL PLASTIC (171.15) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
19.37% 2024
2022
2023
2024
Q1: 30.63%
Med: 49.0%
Q3: 65.86%
Watch

In 2024, the financial autonomy of PHARMAVAL PLASTIC (19.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-18.31 years 2023
2022
2023
Q1: 0.0 years
Med: 1.09 years
Q3: 2.9 years
Excellent -42 pts over 2 years

In 2023, the repayment capacity of PHARMAVAL PLASTIC (-18.31) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 138.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

138.557

Liquidity indicators evolution
PHARMAVAL PLASTIC

Sector positioning

Liquidity ratio
138.56 2024
2022
2023
2024
Q1: 173.28
Med: 264.79
Q3: 378.42
Watch

In 2024, the liquidity ratio of PHARMAVAL PLASTIC (138.56) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
-22.71x 2023
2022
2023
Q1: 0.0x
Med: 2.21x
Q3: 7.71x
Watch -7 pts over 2 years

In 2023, the interest coverage of PHARMAVAL PLASTIC (-22.7x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMAVAL PLASTIC

Positioning of PHARMAVAL PLASTIC in its sector

Comparison with sector Fabrication de pièces techniques à base de matières plastiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (46 transactions). This range of 21 792€ to 255 225€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
21k€ 72k€ 255k€
72 619 € Range: 21 792€ - 255 225€
NAF 5 all-time
How is this estimate calculated?

This estimate is based on the analysis of 46 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de pièces techniques à base de matières plastiques)

Compare PHARMAVAL PLASTIC with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de pièces techniques à base de matières plastiques

Frequently asked questions about PHARMAVAL PLASTIC

What is the revenue of PHARMAVAL PLASTIC ?

The revenue of PHARMAVAL PLASTIC in 2023 is 3.9 M€.

Is PHARMAVAL PLASTIC profitable?

Yes, PHARMAVAL PLASTIC generated a net profit of 41 k€ in 2024.

Where is the headquarters of PHARMAVAL PLASTIC ?

The headquarters of PHARMAVAL PLASTIC is located in LE VAUDREUIL (27100), in the department Eure.

Where to find the tax return of PHARMAVAL PLASTIC ?

The tax return of PHARMAVAL PLASTIC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMAVAL PLASTIC operate?

PHARMAVAL PLASTIC operates in the sector Fabrication de pièces techniques à base de matières plastiques (NAF code 22.29A). See the 'Sector positioning' section above to compare the company with its competitors.